"2019年1月より、土曜日の診療は第１・３・５週のみとなりました。最新情報は病院ホームページでご確認ください。"

During the past decade, Tokyo Saiseikai Central Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tokyo Saiseikai Central Hospital" #1 sponsor was "Chugai Pharmaceutical" with 2 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Mitsubishi Tanabe Pharma America Inc." with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tokyo Saiseikai Central Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Tokyo Saiseikai Central Hospital" are "EPP" (2 trials), "Low Back Pain" (2 trials), "Obesity" (2 trials), "XLP" (2 trials) and "Acute Ischemic Stroke" (1 trials). Many other conditions were trialed in "Tokyo Saiseikai Central Hospital" in a lesser frequency.

Most popular intervention types in "Tokyo Saiseikai Central Hospital" are "Drug" (9 trials), "Biological" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Tirzepatide" (2 trials), "Celecoxib" (1 trials), "Golimumab" (1 trials) and "Guselkumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokyo Saiseikai Central Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Tokyo Saiseikai Central Hospital". 1 are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Tokyo Saiseikai Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tokyo Saiseikai Central Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".